Table 3.
Single factor analysis [n (%)]
| Clinicopathological features | Good prognosis group (n = 42) | Poor prognosis group (n = 26) | X2 value | P value |
|---|---|---|---|---|
| Age | 5.635 | 0.018 | ||
| < 48 | 25 (59.52) | 9 (34.62) | ||
| ≥ 48 | 17 (40.48) | 17 (65.38) | ||
| Gender | 0.027 | 0.869 | ||
| male | 17 (40.48) | 10 (38.46) | ||
| female | 25 (59.52) | 16 (61.54) | ||
| BMI (kg/m2) | 4.317 | 0.038 | ||
| ≤ 23 | 27 (64.29) | 10 (38.46) | ||
| > 23 | 15 (35.71) | 16 (61.54) | ||
| Average duration (month) | 4.484 | 0.034 | ||
| ≤ 42 | 24 (57.14) | 8 (30.77) | ||
| > 42 | 18 (42.86) | 18 (69.23) | ||
| Smoking history (cases) | 0.476 | 0.490 | ||
| Yes | 19 (45.24) | 14 (53.85) | ||
| No | 23 (54.76) | 12 (46.15) | ||
| Drinking history (cases) | 0.183 | 0.669 | ||
| Yes | 22 (52.38) | 15 (57.69) | ||
| No | 20 (47.62) | 11 (42.31) | ||
| IL-6 (ng/L) | 4.741 | 0.030 | ||
| ≤ 13 | 29 (69.05) | 11 (42.31) | ||
| > 13 | 13 (30.95) | 15 (57.69) | ||
| IL-10 (ng/L) | 3.985 | 0.046 | ||
| ≤ 32 | 25 (59.52) | 9 (34.62) | ||
| > 32 | 17 (40.48) | 17 (65.38) | ||
| TNF-α (ng/L) | 5.182 | 0.023 | ||
| ≤ 21 | 28 (66.67) | 10 (38.46) | ||
| > 21 | 14 (33.33) | 16 (61.54) |